MIF and streptococcal pneumonia: Previous studies have identified MIF as a potential biomarker and therapeutic target for acute infection38 and sepsis39, with its expression levels correlating with sepsis incidence and mortality rates40, as well as in Streptococcus pneumoniae infections41.